drug delivery

from technology

to therapy

We empower safe self-administration of liquid drugs through the patient-centric development and manufacture of intelligent injection devices that improve the efficiency and efficacy of therapy.

Reliability and
success in therapy

Our innovative product platforms and related service portfolios assist you every step of the way – leading to an advanced combination of drug and device that is as time-saving and economical for your company as it is safe and convenient in therapy. We support you at every stage – from technology to therapy.

Haselmeier celebrates 100 years of quality in innovation

Over the past century, Haselmeier has been an active and innovative presence in the healthcare market. With our high technical competence and
our inventive spirit we have established ourselves as a reliable partner in the market.

Haselmeier 100years_RGB

  • Our services for your projects

  • Our services for your projects

  • Our services for your projects

  • Our services for your projects

Clinical trials

Haselmeier is ideally placed to support you during your clinical trials – and beyond. Our self-injection pens can help reduce risk and shorten time-to-market, helping pharmaceutical companies to address their major priorities in this area.

Learn more

Pharmaceutical manufacturing

Haselmeier offers comprehensive, certified pharmaceutical manufacturing services – from assembly to labeling and packaging. As a result, we are able to support pharmaceutical and biotechnological companies with their drug manufacturing challenges.

Learn more

Product development

Whether you are looking for a customized pen or a platform pen solution, Haselmeier offers product development pathways designed to fit your specific requirements.

Learn more

Medical device regulations

Haselmeier has extensive experience in working with regulatory authorities and can provide comprehensive, efficient support with device registration.

  • 03.08
  • 2020
  • News

Pharmapack Europe in Paris is postponed to May 2021

Stuttgart, Germany, August 3, 2020: Pharmapack Europe in Paris is postponed to May 2021

  • 05.05
  • 2020
  • News

Dr. Marco Linari becomes new CEO of the Haselmeier Group

Stuttgart, Germany, May 5, 2020: We are pleased to inform you that Dr. Marco Linari has been appointed Chief Executive Officer (CEO) of the Haselmeier Group effective May 1, 2020.

  • 04.05
  • 2020
  • News

D-Flex® a new generation of manual injection pens from Haselmeier wins Red Dot for outstanding design quality

Stuttgart, Germany, May 6, 2020 - The Red Dot Jury has made its decision: The D-Flex® emerged victorious from the Red Dot Award: Product Design 2020 and won a Red Dot for its good design quality.

  • Areas of care

  • Areas of care

  • Areas of care

  • Areas of care

Diabetes GLP-1

Haselmeier offers pen solutions that support safe and efficient self-injection of GLP-1 – helping diabetes patients to manage their condition, and so aiding efforts to reduce costs and improve quality of care.

Diabetes Insulin

Haselmeier offers customizable injection pens and platform solutions that help type 1 and type 2 diabetes patients to self-administer insulin, promoting better compliance and more effective treatment.


We support convenience and compliance in osteoporosis treatment. The D-Flex pen can significantly improve therapy efficiency, allowing patients to treat themselves safely and discreetly on a long-term basis.


Haselmeier's customizable pen solutions are suitable for use in some areas of oncology, supporting quality of care in this growing clinical domain. The solutions could improve patients' quality of life and create a basis for reliable and successful therapy at home.

Good Design Award

The D-Flex® is also state-of-the-art in design and awarded by The Chicago Athenaeum: Museum of Architecture and Design, 2016.

Red Dot Award 2020

The D-Flex® a new generation of manual injection pens from Haselmeier wins Red Dot Award 2020 for outstanding design quality.



Let´s create the future of connected solutions

Our new platform supports a fast way to connected commercial devices and better therapy efficiency for patients around the world.


Customized drug

delivery – from

technology to therapy

Ready to tackle your

future challenges

At Haselmeier, we are here to support you from early development and manufacturing to packaging and delivery.